Zeina A Nahleh

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi Multitargeted therapy in estrogen receptor-positive, human epidermal growth factor receptor-2-positive breast cancer
    Zeina A Nahleh
    Division of Hematology-Oncology, University of Cincinnati Medical Center, The Barrett Cancer Center, Cincinnati, OH 45267, USA
    Am J Clin Oncol 28:631-3. 2005
  2. ncbi Hormonal therapy for male breast cancer: A different approach for a different disease
    Zeina A Nahleh
    Department of Internal Medicine, Division of Hematology Oncology, The Barrett Cancer Center, University of Cincinnati, 234 Goodman Avenue, ML 0501, Cincinnati, OH 45267, USA
    Cancer Treat Rev 32:101-5. 2006
  3. ncbi Male breast cancer: a gender issue
    Zeina Nahleh
    Breast Oncology Program, Division of Hematology Oncology, University of Cincinnati, Cincinnati, OH 45267, USA
    Nat Clin Pract Oncol 3:428-37. 2006
  4. ncbi Male breast cancer in the veterans affairs population: a comparative analysis
    Zeina A Nahleh
    Division of Hematology Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Cancer 109:1471-7. 2007
  5. ncbi Symptom management needs of oncology outpatients
    Kyra M Whitmer
    College of Nursing, University of Cincinnati, Cincinnati, Ohio 45221 0038, USA
    J Palliat Med 9:628-30. 2006
  6. ncbi Molecularly targeted therapy in breast cancer: the new generation
    Zeina A Nahleh
    Division of Hematology Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R, 4HWCRC, Detroit, MI 48201, USA
    Recent Pat Anticancer Drug Discov 3:100-4. 2008

Detail Information

Publications6

  1. ncbi Multitargeted therapy in estrogen receptor-positive, human epidermal growth factor receptor-2-positive breast cancer
    Zeina A Nahleh
    Division of Hematology-Oncology, University of Cincinnati Medical Center, The Barrett Cancer Center, Cincinnati, OH 45267, USA
    Am J Clin Oncol 28:631-3. 2005
  2. ncbi Hormonal therapy for male breast cancer: A different approach for a different disease
    Zeina A Nahleh
    Department of Internal Medicine, Division of Hematology Oncology, The Barrett Cancer Center, University of Cincinnati, 234 Goodman Avenue, ML 0501, Cincinnati, OH 45267, USA
    Cancer Treat Rev 32:101-5. 2006
    ....
  3. ncbi Male breast cancer: a gender issue
    Zeina Nahleh
    Breast Oncology Program, Division of Hematology Oncology, University of Cincinnati, Cincinnati, OH 45267, USA
    Nat Clin Pract Oncol 3:428-37. 2006
    ..This review aims at highlighting the major differences between male and female breast cancer with an emphasis on hormonal therapy, and discusses some of the recent advances in MBC...
  4. ncbi Male breast cancer in the veterans affairs population: a comparative analysis
    Zeina A Nahleh
    Division of Hematology Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Cancer 109:1471-7. 2007
    ..The objective of this retrospective analysis was to compare the characteristics and outcome of patients with MBC and patients with female breast cancer (FBC) in the VA population...
  5. ncbi Symptom management needs of oncology outpatients
    Kyra M Whitmer
    College of Nursing, University of Cincinnati, Cincinnati, Ohio 45221 0038, USA
    J Palliat Med 9:628-30. 2006
    ..What were the needs of outpatients for symptom management?..
  6. ncbi Molecularly targeted therapy in breast cancer: the new generation
    Zeina A Nahleh
    Division of Hematology Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R, 4HWCRC, Detroit, MI 48201, USA
    Recent Pat Anticancer Drug Discov 3:100-4. 2008
    ..The first two agents in this group entering clinic, Lapatinib (GW572016; Tykerb) and SUNITINIB (SU11248; Sutent) are discussed. This review article also includes relevant patents...